首页|SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome

SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome

扫码查看

Huixuan Wu、Junaid Iqbal、Long Li、Hongli Jiang、Chen Chao、Meibiao Zhang、Ou Li、Houde Zhou

展开 >

Department of Metabolism and Endocrinology,National Clinical Research Center for Metabolic Diseases,Hunan Provincial Key Laboratory for Metabolic Bone Diseases,Key Laboratory of Diabetes Immunology,Ministry of Education,The Second Xiangya Hospital of Central South University,Changsha,Hunan 410011,China

Department of Endocrinology and Metabolism,The First People's Hospital of Huaihua,Huaihua,Hunan 418000,China

Department of Metabolism and Endocrinology,San-Sui County Traditional Chinese Medicine Hospital,Qiandongnan Miao and Dong Autonomous Prefecture,Guizhou 556000,China

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaScience & Technology Department of Hunan ProvinceScience & Technology Department of Hunan ProvinceScience & Technology Department of Changsha CityScience & Technology Department of Changsha City

821703360981770880819707622020SK20802015JC3012k1906019kq190111

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(11)
  • 1